Pfizer (PFE) | Stock Overview & Key Data

Pfizer Inc. | Large-cap | Healthcare

$23.97

0.38%

| Pfizer Stock Comparison:

Pfizer vs Eli Lilly and Pfizer vs Johnson & Johnson Pfizer vs Merck & Co Pfizer vs Amgen Pfizer vs Gilead Sciences Pfizer vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Pfizer Performance Comparison

Loading chart data...

Pfizer

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $23.77 High: $24.09

on June 21, 2025

52 Week Range

Low: $20.92 High: $31.54

on April 9, 2025

on July 29, 2024

All-Time High: $61.71 on December 20, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $139.5B

EPS i 1.38

P/E Ratio (TTM) i 17.78

Forward P/E i 8.38

P/B Ratio i 1.54

PEG Ratio i 8.38

Div. Yield i 5.32%

ROE i 8.62%

Beta i 0.491

Debt to Equity i 68.84

Financial Highlights

Profitability

Gross Margin i 79.26%

Operating Margin i 35.17%

Profit Margin i 12.62%

Returns and Earnings

Return on Assets (TTM) i 4.79%

Return on Equity (TTM) i 8.62%

EBITDA i $23.6B

Net Income (TTM) i $7.9B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Last 12-Month Dividend i $1.27

Current Dividend Yield i 5.32%

3-Year Average Dividend Yield i 1.27%

3-Year Average Annual Dividend i $1.52

3-Year Total Dividends i $4.55

Ex-Dividend Date i January 24, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Pfizer PFE	139.52B Large-cap	-2.32%	1.91%	-8.48%	-9.07%	-9.92%	-13.91%	-53.71%	-21.45%
Eli Lilly and LLY	735.57B Mega-cap	-6.91%	2.10%	-9.48%	-0.66%	-1.97%	-11.18%	141.09%	382.12%
Johnson & Johnson JNJ	377.99B Mega-cap	-4.65%	-2.52%	-8.12%	3.68%	4.01%	1.33%	-17.31%	9.38%
Merck & Co MRK	205.18B Mega-cap	-3.24%	1.40%	-16.54%	-19.37%	-20.28%	-39.34%	-14.86%	10.51%
Amgen AMGN	158.59B Large-cap	-2.00%	5.21%	-8.16%	9.85%	11.59%	-6.01%	18.04%	24.39%
Gilead Sciences GILD	136.81B Large-cap	-1.35%	-0.56%	2.48%	17.21%	18.09%	52.82%	71.21%	44.83%

Ownership & Short Interest

Insider Ownership i 0.06%

Institutional Ownership i 67.65%

Shares Short i 105M

Short Ratio i 2.27

Short % of Shares Outstanding i 1.85%

Average 10-Day Volume i 37M

Average 90-Day Volume i 43M

Pfizer Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Pfizer would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is PFE's 52-week high and low?

In the last 52 weeks, Pfizer reached a high of $31.54 (on July 29, 2024) and a low of $20.92 (on April 9, 2025).

What is the market cap and P/E ratio for PFE?

Curious about Pfizer's size and valuation? Its market capitalization stands at 139.52B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.78, and the forward P/E (looking ahead) is 8.38.

Does PFE pay dividends? If so, what's the yield?

Yes, Pfizer is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 5.32%, and the company has paid an average of $1.52 per share annually over the past 3 years.

Who are Pfizer's main competitors or similar companies to consider before investing?

When looking at Pfizer, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Eli Lilly and LLY	735.57B	Healthcare	Drug Manufacturers - General	-11.18%	141.09%
Johnson & Johnson JNJ	377.99B	Healthcare	Drug Manufacturers - General	1.33%	-17.31%
Merck & Co MRK	205.18B	Healthcare	Drug Manufacturers - General	-39.34%	-14.86%
Amgen AMGN	158.59B	Healthcare	Drug Manufacturers - General	-6.01%	18.04%
Gilead Sciences GILD	136.81B	Healthcare	Drug Manufacturers - General	52.82%	71.21%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Pfizer Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Pfizer's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.62%, the Debt to Equity ratio from the most recent quarter is 68.84, and its Gross Profit Margin stands at 79.26%.

What is the recent revenue and earnings growth for PFE?

Looking at Pfizer's growth, its revenue over the trailing twelve months (TTM) was $62B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.80%, and quarterly earnings saw a YoY growth of -4.80%.

How much of PFE stock is held by insiders and institutions?

Wondering who owns Pfizer stock? Company insiders (like executives and directors) hold about 0.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 67.65%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.